0.9624
price down icon2.99%   -0.0297
after-market Handel nachbörslich: .97 0.00765 +0.79%
loading

Mira Pharmaceuticals Inc Aktie (MIRA) Neueste Nachrichten

pulisher
May 22, 2026

MIRA Stock Price, Quote & Chart | MIRA PHARMACEUTICALS INC (NASDAQ:MIRA) - ChartMill

May 22, 2026
pulisher
May 20, 2026

MIRA Pharmaceuticals (MIRA) Q3 2025 Earnings: Why the Beat MattersRising Community Picks - Newser

May 20, 2026
pulisher
May 19, 2026

MIRA Stock Chart | MIRA PHARMACEUTICALS INC (NASDAQ:MIRA) - ChartMill

May 19, 2026
pulisher
May 17, 2026

What's going on with MIRA Pharma stock Tuesday? - MSN

May 17, 2026
pulisher
May 15, 2026

Should You Sell MIRA Pharmaceuticals (MIRA) After -1.24% Drop? 2026-05-15Golden Cross - Newser

May 15, 2026
pulisher
May 15, 2026

MIRA Pharmaceuticals (MIRA) Delivers Q3 2025 Beat — EPS $-0.06 vs $-0.08 ExpectedAnalyst Stock Picks - Newser

May 15, 2026
pulisher
May 15, 2026

MIRA Pharmaceuticals Reports Positive Unblinded Phase 1 Data for Ketamir-2 - Black Hills Pioneer

May 15, 2026
pulisher
May 14, 2026

MIRA Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 14, 2026
pulisher
May 14, 2026

MIRA Pharmaceuticals (MIRA) posts Q1 2026 loss and warns on going concern - Stock Titan

May 14, 2026
pulisher
May 14, 2026

MIRA Pharmaceuticals reports phase 1 results for Ketamir-2 - Investing.com UK

May 14, 2026
pulisher
May 14, 2026

Mira Pharmaceuticals stock gains on Phase 1 trial results By Investing.com - Investing.com South Africa

May 14, 2026
pulisher
May 14, 2026

Mira Pharmaceuticals stock gains on Phase 1 trial results - Investing.com

May 14, 2026
pulisher
May 14, 2026

MIRA Pharmaceuticals reports phase 1 results for Ketamir-2 By Investing.com - Investing.com Canada

May 14, 2026
pulisher
May 14, 2026

Chemo nerve damage has no FDA drugs—MIRA advances new Ketamir-2 pill - Stock Titan

May 14, 2026
pulisher
May 13, 2026

MIRA Pharmaceuticals Reports Positive Phase 1 Ketamir-2 Results - TipRanks

May 13, 2026
pulisher
May 13, 2026

MIRA (MIRA) posts positive Phase 1 data and DEA decision on Ketamir-2 - Stock Titan

May 13, 2026
pulisher
May 13, 2026

MIRA Pharmaceuticals Announces Publication of Preclinical Data on SKNY-1 for Obesity and Nicotine Addiction in International Journal of Molecular Sciences 8910 - Minichart

May 13, 2026
pulisher
May 13, 2026

Mira Pharmaceuticals announces peer-reviewed publication of SKNY-1 preclinical data - Investing.com Nigeria

May 13, 2026
pulisher
May 13, 2026

MIRA publishes preclinical study on obesity drug candidate SKNY-1 By Investing.com - Investing.com South Africa

May 13, 2026
pulisher
May 13, 2026

MIRA publishes preclinical study on obesity drug candidate SKNY-1 - Investing.com

May 13, 2026
pulisher
May 13, 2026

MIRA Pharmaceuticals Announces Acceptance of Peer-Reviewed SKNY-1 Manuscript Highlighting Oral Obesity and Nicotine Addiction Drug Candidate - ACCESS Newswire

May 13, 2026
pulisher
May 13, 2026

MIRA highlights SKNY-1 preclinical data in new publication - TipRanks

May 13, 2026
pulisher
May 13, 2026

Fish study: MIRA test pill cuts weight 30% and dampens nicotine-seeking - Stock Titan

May 13, 2026
pulisher
May 13, 2026

MIRA Pharmaceuticals publishes preclinical SKNY-1 study showing weight loss, lipid benefits - TradingView

May 13, 2026
pulisher
May 13, 2026

MIRA Pharmaceuticals (NASDAQ: MIRA) highlights SKNY-1 preclinical obesity and nicotine data - Stock Titan

May 13, 2026
pulisher
May 11, 2026

Is MIRA Pharmaceuticals (MIRA) stock hiding in plain sight? (Wavering) 2026-05-11Crowd Entry Points - Newser

May 11, 2026
pulisher
May 10, 2026

Number of shareholders of MIRA Pharmaceuticals, Inc. – NASDAQ:MIRA - TradingView

May 10, 2026
pulisher
May 06, 2026

MIRA Pharmaceuticals Reports Mira-55 Shows No THC- or Rimonabant-Associated CNS Side Effects in Preclinical Studies - ACCESS Newswire

May 06, 2026
pulisher
Apr 23, 2026

MIRA Pharmaceuticals (MIRA) Top Loser | Q3 2025: Profit SurprisesPost Earnings - UBND thành phố Hải Phòng

Apr 23, 2026
pulisher
Apr 22, 2026

Should I buy MIRA Pharmaceuticals (MIRA) stock right now | Q3 2025: EPS Exceeds ExpectationsMargin of Safety - UBND thành phố Hải Phòng

Apr 22, 2026
pulisher
Apr 16, 2026

MIRA Pharmaceuticals (MIRA) Stock: Momentum Analysis (Momentum Building) 2026-04-16Low Volatility Stocks - Xã Vĩnh Công

Apr 16, 2026
pulisher
Apr 14, 2026

Stock List: Research Stocks from Around the World - GuruFocus

Apr 14, 2026
pulisher
Apr 09, 2026

Aug Summary: How does MIRA Pharmaceuticals Inc compare to its peersWeekly Investment Recap & AI Driven Stock Movement Reports - baoquankhu1.vn

Apr 09, 2026
pulisher
Apr 07, 2026

Is MIRA Pharmaceuticals (MIRA) Stock Good for Active Traders | Price at $1.03, Down 4.63%Social Momentum Signals - Newser

Apr 07, 2026
pulisher
Apr 07, 2026

MIRA Pharmaceuticals, Inc.: Fundamental Analysis and Financial Ratings | K6S | US60458C1045 - marketscreener.com

Apr 07, 2026
pulisher
Apr 06, 2026

MIRA Pharmaceuticals : Investor Presentation - marketscreener.com

Apr 06, 2026
PFE PFE
$25.85
price down icon 0.41%
$133.75
price up icon 0.00%
$335.94
price down icon 1.10%
NVO NVO
$44.20
price down icon 1.67%
NVS NVS
$150.80
price down icon 0.90%
AZN AZN
$187.26
price down icon 0.09%
Kapitalisierung:     |  Volumen (24h):